100
Views
5
CrossRef citations to date
0
Altmetric
Case Report

Late Onset Macular Oedema in a Patient with Multiple Sclerosis Treated with Fingolimod

ORCID Icon, , , , , & show all
Pages 61-64 | Received 15 Jun 2020, Accepted 04 Sep 2020, Published online: 06 Oct 2020
 

ABSTRACT

Macular oedema is a rare complication of fingolimod treatment. It usually presents within 3–4 months, but occasionally presents later. It can resolve without treatment despite continuation of fingolimod treatment. Herein we report a case of very late onset macular oedema in a 49-year-old woman with multiple sclerosis treated with fingolimod for 7 years. The patient presented with blurred vision in both eyes with visual acuities of 20/32 in her right eye and 20/25 in her left eye. She had macular oedema, that without discontinuing fingolimod treatment, resolved after 1 month.

Patient consent and ethics statement

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Declaration of interest statement

The authors declare that there are no conflicts of interest. The authors alone are responsible for the writing and content of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.